BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9175798)

  • 1. Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings.
    Simonaro CM; Haskins ME; Kunieda T; Evans SM; Visser JW; Schuchman EH
    Transplantation; 1997 May; 63(10):1386-93. PubMed ID: 9175798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation.
    Simonaro CM; Haskins ME; Abkowitz JL; Brooks DA; Hopwood JJ; Zhang J; Schuchman EH
    Gene Ther; 1999 Jan; 6(1):107-13. PubMed ID: 10341882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of feline arylsulphatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation.
    Gasper PW; Thrall MA; Wenger DA; Macy DW; Ham L; Dornsife RE; McBiles K; Quackenbush SL; Kesel ML; Gillette EL
    Nature; 1984 Nov 29-Dec 5; 312(5993):467-9. PubMed ID: 6438532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone changes in mucopolysaccharidosis VI in cats and the effects of bone marrow transplantation: mechanical testing of long bones.
    Norrdin RW; Simske SJ; Gaarde S; Schwardt JD; Thrall MA
    Bone; 1995 Nov; 17(5):485-9. PubMed ID: 8579961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.
    Fillat C; Simonaro CM; Yeyati PL; Abkowitz JL; Haskins ME; Schuchman EH
    J Clin Invest; 1996 Jul; 98(2):497-502. PubMed ID: 8755662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT.
    McGovern MM; Ludman MD; Short MP; Steinfeld L; Kattan M; Raab EL; Krivit W; Desnick RJ
    Birth Defects Orig Artic Ser; 1986; 22(1):41-53. PubMed ID: 3083886
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone mineral density in feline mucopolysaccharidosis VI measured using dual-energy X-ray absorptiometry.
    Turner AS; Norrdin RW; Gaarde S; Connally HE; Thrall MA
    Calcif Tissue Int; 1995 Sep; 57(3):191-5. PubMed ID: 8574935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine glycosaminoglycan concentrations in mucopolysaccharidosis VI-affected cats following bone marrow transplantation or leukocyte infusion.
    Dial SM; Byrne T; Haskins M; Gasper PW; Rose B; Wenger DA; Thrall MA
    Clin Chim Acta; 1997 Jul; 263(1):1-14. PubMed ID: 9247723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation.
    Krivit W; Pierpont ME; Ayaz K; Tsai M; Ramsay NK; Kersey JH; Weisdorf S; Sibley R; Snover D; McGovern MM
    N Engl J Med; 1984 Dec; 311(25):1606-11. PubMed ID: 6150438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in the feline model of arylsulfatase B deficiency.
    Wenger DA; Gasper PW; Thrall MA; Dial SM; LeCouteur RA; Hoover EA
    Birth Defects Orig Artic Ser; 1986; 22(1):177-86. PubMed ID: 3083883
    [No Abstract]   [Full Text] [Related]  

  • 11. Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.
    Crawley AC; Yogalingam G; Muller VJ; Hopwood JJ
    J Clin Invest; 1998 Jan; 101(1):109-19. PubMed ID: 9421472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation.
    Sohn YB; Park SW; Kim SH; Cho SY; Ji ST; Kwon EK; Han SJ; Oh SJ; Park YJ; Ko AR; Paik KH; Lee J; Lee DH; Jin DK
    Am J Med Genet A; 2012 May; 158A(5):1158-63. PubMed ID: 22495825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice.
    Miranda SR; Erlich S; Friedrich VL; Haskins ME; Gatt S; Schuchman EH
    Transplantation; 1998 Apr; 65(7):884-92. PubMed ID: 9565090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for feline mucopolysaccharidosis I.
    Ellinwood NM; Colle MA; Weil MA; Casal ML; Vite CH; Wiemelt S; Hasson CW; O'Malley TM; He X; Prociuk U; Verot L; Melniczek JR; Lannon A; Aguirre GD; Knox VW; Evans SM; Vanier MT; Schuchman EH; Walkley SU; Haskins ME
    Mol Genet Metab; 2007 Jul; 91(3):239-50. PubMed ID: 17482862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease.
    Walkley SU; Thrall MA; Haskins ME; Mitchell TW; Wenger DA; Brown DE; Dial S; Seim H
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):536-44. PubMed ID: 16150124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.
    Crawley AC; Niedzielski KH; Isaac EL; Davey RC; Byers S; Hopwood JJ
    J Clin Invest; 1997 Feb; 99(4):651-62. PubMed ID: 9045867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology of leukocytes from cats affected with alpha-mannosidosis and mucopolysaccharidosis VI (MPS VI).
    Alroy J; Freden GO; Goyal V; Raghavan SS; Schunk KL
    Vet Pathol; 1989 Jul; 26(4):294-302. PubMed ID: 2503918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.
    Herskhovitz E; Young E; Rainer J; Hall CM; Lidchi V; Chong K; Vellodi A
    J Inherit Metab Dis; 1999 Feb; 22(1):50-62. PubMed ID: 10070618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological characteristics of mucopolysaccharidosis VI in the rat.
    Yoshida M; Ikadai H; Maekawa A; Takahashi M; Nagase S
    J Comp Pathol; 1993 Aug; 109(2):141-53. PubMed ID: 8245230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.
    Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA
    Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.